FLUCELVAX QUADRIVALENT (PRE-FILLED SYRINGE) (influenza a virus a/washington/19/2020 (h1n1) antigen (mdck cell derived, propiolactone inactivated), influenza a virus a/tasmania/503/2020 (h3n2) antigen (mdck cell derived, propiolactone inactivated), influenza b virus b/darwin/7/2019 antigen (mdck cell derived, propiolactone inactivated), influenza b virus b/singapore/inftt-16-0610/2016 antigen (mdck cell derived, propiolactone inactivated)) injection, suspension FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL) (influenza a virus a/washington/19/2020 (h1n1) antigen (mdck cell derived, propiolactone inactivated), influenza a virus a/tasmania/503/2020 (h3n2) antigen (mdck cell derived, propiolactone inactivated), influenza b virus b/darwin/7/2019 antigen (mdck cell derived, propiolactone inactivated), influenza b virus b/singapore/inftt-16-0610/2016 antigen (mdck cell derived, propiolactone inactivated)) injection, suspension [Seqirus Inc.]

Updated Date: Tue, 13 Jul 2021 00:00:00 EDT
Source: DailyMed Drug Label Updates - Category: Drugs & Pharmacology Source Type: alerts